Literature DB >> 12838272

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment.

Jessica E Malberg1, Ronald S Duman.   

Abstract

Adult hippocampal neurogenesis has been demonstrated in several species and is regulated by both environmental and pharmacological stimuli. The present study seeks to determine whether hippocampal proliferation and neurogenesis are altered in adult animals exposed to inescapable shock (IS) in the learned helplessness model of depression. We report that exposure to avoidance testing, regardless of pre-exposure to IS, decreases cell proliferation in the hippocampus, extending previous studies demonstrating downregulation of neurogenesis by exposure to acute stressors. In addition, when the analysis was conducted 9 days after exposure to IS we observed a significant decrease in cell proliferation compared to nonshocked animals. Administration of fluoxetine, a serotonin selective reuptake inhibitor, from days 2-8 blocked the downregulation of cell proliferation resulting from IS. Fluoxetine treatment also reversed the deficit in escape latency observed in animals exposed to IS. Finally, at the 9 day time point, there was no significant difference in blood levels of corticosterone between nonshocked and IS exposed animals, indicating that the decreased cell proliferation that is observed is not due to increased levels of this adrenal steroid. These findings demonstrate that exposure to IS, which results in a state of behavioral despair, decreases hippocampal cell proliferation and that this effect can be reversed by fluoxetine treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12838272     DOI: 10.1038/sj.npp.1300234

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  233 in total

Review 1.  Depression, antidepressants, and neurogenesis: a critical reappraisal.

Authors:  Nicola D Hanson; Michael J Owens; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis.

Authors:  Patricia A Zunszain; Christoph Anacker; Annamaria Cattaneo; Shanas Choudhury; Ksenia Musaelyan; Aye Mu Myint; Sandrine Thuret; Jack Price; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2011-11-09       Impact factor: 7.853

3.  Dominance hierarchy influences adult neurogenesis in the dentate gyrus.

Authors:  Yevgenia Kozorovitskiy; Elizabeth Gould
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

4.  Strain differences in the effects of chronic corticosterone exposure in the hippocampus.

Authors:  G E Hodes; B R Brookshire; T E Hill-Smith; S L Teegarden; O Berton; I Lucki
Journal:  Neuroscience       Date:  2012-06-23       Impact factor: 3.590

5.  A small molecule accelerates neuronal differentiation in the adult rat.

Authors:  Heiko Wurdak; Shoutian Zhu; Kyung Hoon Min; Lindsey Aimone; Luke L Lairson; James Watson; Gregory Chopiuk; James Demas; Bradley Charette; Rajkumar Halder; Eranthie Weerapana; Benjamin F Cravatt; Hollis T Cline; Eric C Peters; Jay Zhang; John R Walker; Chunlei Wu; Jonathan Chang; Tove Tuntland; Charles Y Cho; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

Review 6.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

7.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

8.  Neuropsychopharmacology: Reflections on 40 Volumes.

Authors:  Alan Frazer
Journal:  Neuropsychopharmacology       Date:  2015-12       Impact factor: 7.853

9.  Fluoxetine and the dentate gyrus: memory, recovery of function, and electrophysiology.

Authors:  Julian R Keith; Ying Wu; Jonathon R Epp; Robert J Sutherland
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

10.  The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus.

Authors:  Smita Thakker-Varia; Jennifer Jernstedt Krol; Jacob Nettleton; Parizad M Bilimoria; Debra A Bangasser; Tracey J Shors; Ira B Black; Janet Alder
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.